Security key
29446K106
Equillium, Inc. - Common Stock, par value $0.0001 per share (EQ)
CUSIP: 29446K106
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 8,659,890
- Total 13F value
- $3,389,920
- Share change
- -44,872
- Put/Call ratio
- 0.75%
- SEC-reported price per share
- $0.39
- Number of holders
- 23
- Value change
- -$48,129
- Number of buys
- 8
- Number of sells
- 9
- Shares outstanding
- 66,704,586
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
23
Top holders
10
EQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Equillium, Inc. SEC filings
Equillium, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29446K106
Recent filing periods:
Ownership snapshot
Top reported holders of EQ - Equillium, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Decheng Capital LLC
Disclosed value leader
Decheng Capital LLC
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 6.7%
Showing 1-6 of 15 holder rows.
Quick read
Decheng Capital LLC leads the comparable SEC ownership view at 6.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Decheng Capital LLC's linked filing trail.
Comparable ownership
Top 5
Decheng Capital LLC
6.7%
TAKEDA PHARMACEUTICAL CO LTD
2.7%
VANGUARD GROUP INC
1.3%
Cota Capital Management, LLC
0.84%
RENAISSANCE TECHNOLOGIES LLC
0.39%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Decheng Capital LLC |
13F
Company
|
6.7%
|
$3,327,476
4,447,308 shares
|
— | 31 Dec 2024 |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
Company
|
2.7%
|
$1,368,733
1,824,977 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
1.3%
|
$629,777
841,948 shares
|
— | 31 Dec 2024 |
| Cota Capital Management, LLC |
13F
Company
|
0.84%
|
$420,696
562,278 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.39%
|
$195,579
261,400 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.31%
|
$152,954
204,385 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
8,659,890
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
23
Q1 2025 holders
23
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend